Let's hope BOT doesn't do an encore performance by releasing stellar revenue figures in the next quarterly
... and then immediately doing a CR to their mates to raise funds for the next drug in the pipeline.
Ann: FDA Approves Sofdra, page-489
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.005(1.47%) |
Mkt cap ! $624.4M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 35.0¢ | 33.0¢ | $1.534M | 4.518M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 82410 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 91007 | 4 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |